← Leaderboards
Todd W Bauer
University Of Virginia
$987,018
Attributed
$1,974,035
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $461.4K · FY2009–25$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,974,035 · 2
By mechanism
R01$1,822,535 · 1
R03$151,500 · 1
Top collaborators
- David Wotton4 shared
- J Thomas Parsons2 shared
Most similar at University Of Virginia
Same institution · by research overlap
- Li Li$10,636,659
- Douglas A Bayliss$19,211,614
- Norbert Leitinger$10,025,679
- Kelly McLean Shaffer$2,408,572
- Timothy Brandon Ware$159,125
Others in their field
Top investigators on “Mouse Model”
- Dennis R. Burton · Scripps Research Institute$280,661,242
- David Heimbrook · Leidos Biomedical Research, Inc.$84,491,283
- Kc Kent Lloyd · University Of California At Davis$74,285,556
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Stanley B Prusiner · University Of California San Francisco$61,905,394
- Ed Lein · Allen Institute$59,425,748
Research focus
Mouse ModelXenograft ModelTumor ProgressionNeoplasm MetastasisEnvironmentGrowthMalignant NeoplasmsTumorXenograft ProcedureAcetylationAnchorage-Independent GrowthCancer CellCancer ModelCarcinogensColonic NeoplasmsColon TumorigenesisAgarChromatinChemical CarcinogenBindingCitratesButyratesCoenzyme A LigasesColon Carcinoma
Grant awards (6)
The role of ACSS2 in colon cancer$457,896
R01 · FY2025 · CA
The role of ACSS2 in colon cancer$442,993
R01 · FY2024 · CA
The role of ACSS2 in colon cancer$461,405
R01 · FY2023 · CA
The role of ACSS2 in colon cancer$460,241
R01 · FY2022 · CA
A primary human xenograft model of pancreatic cancer.$75,750
R03 · FY2010 · CA · contact PI
A primary human xenograft model of pancreatic cancer.$75,750
R03 · FY2009 · CA · contact PI